Lorlatinib for advanced ROS1+non-small cell lung cancer (NSCLC): Efficacy and safety data from IFCT-1803 LORLATU expanded access program (EAP) cohort

Affiliation auteurs!!!! Error affiliation !!!!
TitreLorlatinib for advanced ROS1+non-small cell lung cancer (NSCLC): Efficacy and safety data from IFCT-1803 LORLATU expanded access program (EAP) cohort
Type de publicationJournal Article
Year of Publication2020
AuteursGirard N., S. Girodet G, Duruisseaux M., Avrillon V., Roch B., Otto J., Cadranel J., Coudurier M., Moro-Sibilot D., Egenod T., Lamy R., Bennouna J., Zalcman G., Ricordel C., Tillon J., Odier L., Besse B., Missy P., Westeel V., Baldacci S.
JournalANNALS OF ONCOLOGY
Volume31
PaginationS865
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1016/j.annonc.2020.08.1663